Business Wire

Verimatrix Launches XTD Velocity Partner Alliance to Accelerate Global Channel Sales

19.3.2025 17:45:00 CET | Business Wire | Press release

Share

Risk Associates, a Middle East leader, joins the partner program to drive Verimatrix XTD app protection, threat detection & Response managed services to their customers

Regulatory News:

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity Partner Alliance, a global channel sales program designed to empower partners with best-in-class application protection solutions. As part of this initiative, Risk Associates, a leading Managed Security Services Provider (MSSP), has joined the program to offer Verimatrix XTD Enterprise Suite to banks and enterprises across Australia, Bahrain, Saudi Arabia, and the UAE.

The XTD Velocity Partner Alliance, spearheaded by Simon Emery, Global Head of Strategic Partnerships at Verimatrix, provides resellers, MSSPs, system integrators, and cybersecurity firms with comprehensive resources to deliver AI-powered mobile app shielding, endpoint threat detection, and response solutions. The program enhances channel sales by offering:

  • Resell XTD & Deliver Managed Services – Offer 24/7 app hardening with AI-driven threat detection to stop cyberattacks.
  • Expert Training & Certification – Gain the skills to deploy and integrate Verimatrix XTD with confidence.
  • Marketing & Sales Power – Access co-branded campaigns, deal registration, and exclusive marketing funds.
  • Innovate & Collaborate – Partner on cutting-edge security solutions through joint development and certification.

“With the Verimatrix XTD Velocity Partner Alliance, we're redefining how cybersecurity providers and channel partners collaborate to accelerate app protection at scale,” said Jon Samsel, Global Head of Cybersecurity Business at Verimatrix. “Our expanded partnership with Risk Associates has already resulted in six banks choosing Verimatrix to safeguard their applications—and we’re just getting started. Strategic alliances like this ensure that financial institutions can leverage our award-winning technologies to protect their app code, customer data, and brand reputation with confidence.”

Having successfully deployed Verimatrix XTD app protection for fintech and banking institutions since last year, Risk Associates brings over 20 years of cybersecurity expertise and serves as a trusted MSSP for top brands and startups across the region.

It’s dedication to shielding businesses from the latest threats, including mobile-based attacks, matches well with the opportunity to offer its customers the Verimatrix XTD suite that powerfully protects mobile app owners from reverse engineering, application repackaging attacks, dynamic modification, man-in-the-device attacks while also providing anti-Frida, anti-emulator and anti-debugger defenses.

“Risk Associates welcomes this partnership with Verimatrix to offer proven protections for vital mobile apps that are relied upon by millions in the regions we serve,” said Aziz A. Rahim, Chief Operating Officer at Risk Associates. “Verimatrix’s powerful yet easily-to-implement XTD technologies provide tremendous value to customers through extensive threat visibility and remediation that is often lacking in vulnerable apps that remain crucial for enterprises and their users.”

As part of the XTD Velocity Partner Alliance, Risk Associates now offers the following Verimatrix XTD platform solutions:

Verimatrix XTD Enterprise includes:

  • XTD Protect for iOS
  • XTD Protect for Android
  • XTD Detection & Response

Additional Verimatrix solutions available for resale include:

  • XTD Protect for Desktop/Embedded
  • XTD Protect for Web
  • XTD Protect Native for iOS
  • XTD Protect Native for Android
  • XTD Managed Services

For more information on joining the Verimatrix XTD Velocity Partner Alliance, visit https://www.verimatrix.com/partners.

About Risk Associates
At Risk Associates, our passion is simplifying compliance for organizations in an increasingly complex regulatory environment. As a UKAS-accredited certification body, we specialize in offering certifications and assessments that enable businesses to meet international standards, minimize risks, and safeguard their operations. We take pride in our role as PCI GEAR (Global Executive Assessor Roundtable) Advisors, ranking among the top 30 QSA companies globally.

Risk Associate’s industry recognition, encompassing PCI DSS, PCI PIN, PCI P2PE, PCI TSP, PCI SSF, PCI SSLC, PCI ASV, PCI 3DS, CSA STAR, SOC I and II, ISO/IEC 27001, ISO/IEC 27701, ISO/IEC 22301, ISO/IEC 20000, HIPAA, HITRUST, GDPR, SWIFT, MARS-E, and NIST, serves as a testament to our expertise, knowledge and compliance competence. As a Qualified Security Assessor (PCI-QSA) company approved by the Payment Card Industry (PCI) Security Standards Council, we are acknowledged as an industry leader specializing in cybersecurity, compliance, information governance, strategy and training. Our services extend across Australia, Europe, the Middle East, Asia Pacific and North America. Visit www.riskassociates.com. Visit www.riskassociates.com.

About Verimatrix
Verimatrix (Euronext Paris: VMX, FR0010291245) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure premium movies, live streaming sports, sensitive financial and healthcare data, mission-critical mobile applications, and much more. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319818660/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release

Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye